Detalle Publicación

ARTÍCULO
Phenotypic screening to discover novel chemical series as efficient antihemorrhagic agents
Título de la revista: ACS MEDICINAL CHEMISTRY LETTERS
ISSN: 1948-5875
Volumen: 9
Número: 5
Páginas: 428 - 433
Fecha de publicación: 2018
Lugar: WOS
Resumen:
In an effort to find novel chemical series as antifibrinolytic agents, we explore alpha-phenylsulfonyl-alpha-spiropiperidines bearing different zinc-binding groups (ZBGs) to target those metalloproteinases involved in the fibrinolytic process: MMP3 and MMP10. Surprisingly, all these new chemical series were inactive against these metalloproteinases; however, several new molecules retained the antifibrinolytic activity in a phenotypic functional assay using thromboelastometry and human whole blood. Further optimization led to compound 38 as a potent antifibrinolytic agent in vivo, three times more efficacious than the current standard-of-care (tranexamic acid, TXA) at 300 times lower dose. Finally, in order to decipher the underlying mode-of action leading to this phenotypic response, an affinity-based probe 39 was successfully designed to identify the target involved in this response: a potentially unknown mechanism-of-action in the fibrinolytic process.